Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | PPM1B | O75688 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3641631 | 1.00 | ALDH1A1 (0.46) | ALDH1A1LMNAPPM1BPTPN1PPP1CC | |
| SCHEMBL3747168 | 1.00 | ALDH1A1 (0.46) | ALDH1A1LMNAPPM1BPTPN1PPP1CC | |
| SCHEMBL4608110 | 0.83 | ALDH1A1 (0.42) | ALDH1A1LMNAPPM1BPTPN1PPP1CC | |
| SCHEMBL4608105 | 0.83 | ALDH1A1 (0.42) | ALDH1A1LMNAPPM1BPTPN1PPP1CC | |
| SCHEMBL4606370 | 0.83 | ALDH1A1 (0.42) | ALDH1A1LMNAPPM1BPTPN1PPP1CC | |
| SCHEMBL812446 | 0.83 | ALDH1A1 (0.42) | ALDH1A1LMNAPPM1BPTPN1PPP1CC | |
| SCHEMBL4606378 | 0.83 | ALDH1A1 (0.42) | ALDH1A1LMNAPPM1BPTPN1PPP1CC | |
| SCHEMBL3744024 | 0.81 | ALDH1A1 (0.33) | ALDH1A1PPM1BPTPN1PPP1CCMAPT | |
| SCHEMBL3639450 | 0.81 | ALDH1A1 (0.33) | ALDH1A1PPM1BPTPN1PPP1CCMAPT | |
| SCHEMBL3751050 | 0.81 | ALDH1A1 (0.33) | ALDH1A1PPM1BPTPN1PPP1CCMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2167621-B1 | ORGANIC COMPOUNDS AS ODORANTS | GIVAUDAN SA (CH) | 2017-10-11 | — | — | EP | disclosed |
| US-9012391-B2 | Organic compounds | GIVAUDAN SA (CH) | 2015-04-21 | — | — | US | disclosed |
| US-20100292128-A1 | Organic Compounds | GIVAUDAN SA (CH) | 2010-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100292128-A1 | Organic Compounds | TRPA1, FASN, OR10J3 | ALDH1A1 99/4885LMNA 1886/4885PPM1B 4002/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.